A Case Study depicting Management of Diabetes Mellitus with Autologous Stem Cells
Abstract
Prabhu Mishra, Deepti Dua1, Nitika Sood and Shaloo Gupta
Diabetes mellitus type 2 is a long-term disorder of the metabolism characterized by elevated levels of sugar in blood, insulin resistance, and relative lack of insulin. Insulin is the main culprit for diabetes mellitus. Beta cells of the pancreatic islets are the producers of this peptide hormone which is considered to be the main anabolic hormone of the body regulating the carbohydrates, fats and protein metabolism by promoting the absorption of, especially, glucose from the blood into fat, liver and skeletal muscle cells. From this study, it seems that stem cell therapy can be a promising approach to manage the long term condition diabetes mellitus. The patients were administered stem cells derived from their bone marrows during the procedure. The levels of blood glucose and glycated hemoglobin (HbA1c) were decreased significantly post procedure in both the patients.